Skip to main content

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 12, Number 12, December 2011

Articles

Pharmacokinetic Concepts Revisited - Basic and Applied
pp. 1983-1990(8)
Authors: Patel, Kashyap; M.J. Kirkpatrick, Carl

Favourites:
ADD

Physiological Changes in the Critically Ill Patient with Sepsis
pp. 1991-1995(5)
Authors: Hosein, Shaun; A. Udy, Andrew; Lipman, Jeffrey

Favourites:
ADD

The Relevance of Drug Volume of Distribution in Antibiotic Dosing
pp. 1996-2001(6)
Authors: Ulldemolins, Marta; Rello, Jordi

Favourites:
ADD
Favourites:
ADD

Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy
pp. 2015-2019(5)
Authors: T. Kielstein, Jan; Burkhardt, Olaf

Favourites:
ADD

ARC - Augmented Renal Clearance
pp. 2020-2029(10)
Authors: A. Udy, Andrew; T. Putt, Michael; J. Boots, Robert; Lipman, Jeffrey

Favourites:
ADD

The Effect of Critical Illness on Drug Distribution
pp. 2030-2036(7)
Authors: Gonzalez, Daniel; J Conrado, Daniela; Theuretzbacher, Ursula; Derendorf, Hartmut

Favourites:
ADD

How to Measure Pharmacokinetics in Critically Ill Patients?
pp. 2037-2043(7)
Authors: Liu, Xin; S. Kruger, Peter; S. Roberts, Michael

Favourites:
ADD

Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
pp. 2044-2061(18)
Authors: B. Bulitta, Jurgen; B. Landersdorfer, Cornelia; Forrest, Alan; V. Brown, Silvia; N. Neely, Michael; T. Tsuji, Brian; Louie, Arnold

Favourites:
ADD

Reducing the Development of Antibiotic Resistance in Critical Care Units
pp. 2062-2069(8)
Authors: P.D. Deege, Marjolein; L. Paterson, David

Favourites:
ADD

Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
pp. 2070-2079(10)
Author: A. Roberts, Jason

Favourites:
ADD
Favourites:
ADD

Structures of TGF-β Receptor Complexes: Implications for Function and Therapeutic Intervention Using Ligand Traps
pp. 2081-2098(18)
Authors: P. Hinck, Andrew; D. O'Connor-McCourt, Maureen

Favourites:
ADD

Biology of Transforming Growth Factor-β Signaling
pp. 2099-2107(9)
Authors: Ikushima, Hiroaki; Miyazono, Kohei

Favourites:
ADD

TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
pp. 2108-2120(13)
Authors: A. van Meeteren, Laurens; Goumans, Marie-Jose; ten Dijke, Peter

Favourites:
ADD

Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
pp. 2121-2137(17)
Authors: T. Buijs, Jeroen; Juarez, Patricia; A. Guise, Theresa

Favourites:
ADD

The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
pp. 2138-2149(12)
Authors: C. Connolly, Erin; J. Akhurst, Rosemary

Favourites:
ADD

TGF-β2 Signaling in High-Grade Gliomas
pp. 2150-2157(8)
Authors: Hau, Peter; Jachimczak, Piotr; Schlaier, Jurgen; Bogdahn, Ulrich

Favourites:
ADD

Transforming Growth Factor Beta in Pancreatic Cancer
pp. 2158-2164(7)
Authors: Hilbig, Andreas; Oettle, Helmut

Favourites:
ADD

Role of TGF-β in Melanoma
pp. 2165-2175(11)
Authors: Busse, A.; Keilholz, U.

Favourites:
ADD

Open Access Antibody Targeting of TGF-β in Cancer Patients
pp. 2176-2189(14)
Authors: Lonning, Scott; Mannick, Joan; M. McPherson, John

Favourites:
ADD

TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
pp. 2190-2202(13)
Authors: E. Ling, Leona; Lee, Wen-Cherng

Favourites:
ADD

The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2
pp. 2203-2213(11)
Authors: Jaschinski, Frank; Rothhammer, Tanja; Jachimczak, Piotr; Seitz, Christian; Schneider, Anneliese; Schlingensiepen, Karl-Hermann

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more